AwardedPOLGoods
Postępowanie w trybie przetargu nieograniczonego na dostawę leków w ramach programu lekowego: Aflibercept, Farycymab, Bewacyzumab i Dexamethazon
- Published
- Published 3 March 2026
- Deadline
- Closed 7 April 2026
Overview
The Municipal Hospital of John Paul II in Elbląg procured the supply of pharmaceutical products (Aflibercept, Farycymab, Bevacizumab, and Dexamethasone) under a pharmaceutical program through an open tender. The contract was awarded on 6 May 2026 for 2,270,573.4 PLN to five suppliers: Abbvie Sp. z o.o., Bayer Sp. z o.o., Neuca S.A., Roche Polska Sp. z o.o., and URTICA sp. z o.o.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 3 March 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- PLN 2,270,573
- Award date
- 6 May 2026
- Contract period
- — → 1 May 2027
- Abbvie Sp. z o.o
- Bayer Sp. z o.o.
- Neuca S.A.
- Roche Polska Sp. z o.o
- URTICA sp.z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 May 2026
Contract Notice
3 March 2026
Contracting authority
Szpital Miejski św. Jana Pawła II w Elblągu
Procuring entityElbląg, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.